Omnicell. has been granted a patent for a medication compounding system that integrates compounding devices with a central computer. The system efficiently manages compounding tasks and includes a method for analyzing syringes using infrared imaging to verify needle attachment and measure syringe size and position. GlobalData’s report on Omnicell gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Omnicell, Automated drug dispensing systems was a key innovation area identified from patents. Omnicell's grant share as of June 2024 was 63%. Grant share is based on the ratio of number of grants to total number of patents.
Medication compounding system with automated syringe analysis
The granted patent US12042632B2 outlines a method for compounding medication that utilizes infrared technology to enhance the accuracy and efficiency of the process. The method involves receiving a syringe in a designated viewing area between an infrared area light source and an infrared digital camera. A digital photograph of the syringe is captured in infrared light, allowing for automatic analysis to determine whether a needle or needle cap is attached. The system also assesses the size and position of the syringe, annotates the photograph with volume indications, and can compute the liquid volume within the syringe. This process can be integrated into a compounding assistance device or a robotic mechanism, facilitating user interaction through prompts displayed on a screen.
Additionally, the method includes capturing a second digital photograph of a container involved in the compounding process using a visible light camera, which is stored alongside the infrared image. The analysis of the syringe's photograph involves evaluating pixel brightness to identify the presence of the needle and the size of the syringe components, such as the plunger. The system can compare the captured images against synthetic models or previously stored photographs to ensure accuracy. This innovative approach aims to streamline medication compounding, reduce errors, and improve overall safety in pharmaceutical practices.
To know more about GlobalData’s detailed insights on Omnicell, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
